methenamine has been researched along with Carcinoma, Squamous Cell in 4 studies
Methenamine: An anti-infective agent most commonly used in the treatment of urinary tract infections. Its anti-infective action derives from the slow release of formaldehyde by hydrolysis at acidic pH. (From Martindale, The Extra Pharmacopoeia, 30th ed, p173)
hexamethylenetetramine : A polycyclic cage that is adamantane in which the carbon atoms at positions 1, 3, 5 and 7 are replaced by nitrogen atoms.
Carcinoma, Squamous Cell: A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Human head and neck squamous cell carcinoma cells transfected with mutant TP53 (SAS/mp53), or with neo vector as a control (SAS/neo), were inoculated subcutaneously into both the hind legs of Balb/cA nude mice." | 1.36 | Usefulness of hexamethylenetetramine as an adjuvant to radiation and cisplatin in the treatment of solid tumors: its independency of p53 status. ( Kashino, G; Kinashi, Y; Liu, Y; Masunaga, S; Nakamura, J; Ohnishi, K; Ohnishi, T; Ono, K; Suzuki, M; Takahashi, A; Tanaka, H; Tano, K; Watanabe, M, 2010) |
| " DXR's encapsulation into pegylated liposomes and combination with HMTA, particularly when administered continuously, apparently reduced the difference in sensitivity to free DXR between the total and Q cell populations." | 1.35 | Usefulness of hexamethylenetetramine in combination with chemotherapy using free and pegylated liposomal doxorubicin in vivo, referring to the effect on quiescent cells. ( Kashino, G; Kinashi, Y; Kono, K; Liu, Y; Masunaga, S; Nakamura, J; Ono, K; Suzuki, M; Tano, K; Watanabe, M; Yoshida, H, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Masunaga, S | 3 |
| Tano, K | 3 |
| Watanabe, M | 3 |
| Kashino, G | 3 |
| Suzuki, M | 3 |
| Kinashi, Y | 3 |
| Ono, K | 3 |
| Nakamura, J | 3 |
| Kono, K | 1 |
| Yoshida, H | 1 |
| Liu, Y | 2 |
| Takahashi, A | 1 |
| Tanaka, H | 1 |
| Ohnishi, K | 1 |
| Ohnishi, T | 1 |
| Huang, TH | 1 |
| Lee, H | 1 |
| Kao, CT | 1 |
4 other studies available for methenamine and Carcinoma, Squamous Cell
| Article | Year |
|---|---|
Evaluation of the potential of hexamethylenetetramine, compared with tirapazamine, as a combined agent with {gamma}-irradiation and cisplatin treatment in vivo.
Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Hypoxia; Cisplatin; Combined Modality | 2009 |
Usefulness of hexamethylenetetramine in combination with chemotherapy using free and pegylated liposomal doxorubicin in vivo, referring to the effect on quiescent cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Squamous Cell; Cell S | 2009 |
Usefulness of hexamethylenetetramine as an adjuvant to radiation and cisplatin in the treatment of solid tumors: its independency of p53 status.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous | 2010 |
Evaluation of the genotoxicity of zinc oxide eugenol-based, calcium hydroxide-based, and epoxy resin-based root canal sealers by comet assay.
Topics: Analysis of Variance; Bismuth; Calcium Hydroxide; Carcinoma, Squamous Cell; Comet Assay; DNA Damage; | 2001 |